Management of electrical storm in Brugada syndrome requires elimination of precipitating factors, isoproterenol, and oral quinidine, followed by ablation if initial measures fail.
What is the recommended treatment approach for electrical storms in patients with Brugada syndrome?
The management of electrical storm in Brugada syndrome requires elimination of precipitating factors, followed by isoproterenol and oral quinidine, with ablation reserved for refractory cases.
Abstract Patients with Brugada syndrome (BrS) not uncommonly suffer from recurrent and recalcitrant ventricular fibrillation episodes, the so‐called “electrical storm” which is malignant and potentially lethal event. While electrical storm in BrS is a therapeutic challenge, fortunately there are effective therapeutic solutions which must be compulsory applied: Elimination of precipitating factors, isoproterenol and oral quinidine are the first 2 therapeutic steps that one must urgently commenced. And if this measure should fail, ablation of the triggering ventricular premature beats and/or substrate ablation at the anterior aspect of the right ventricular outflow tract should be performed.
Veerakul et al. (Thu,) conducted a review in Brugada syndrome with electrical storm. Isoproterenol, oral quinidine, and ablation was evaluated. Management of electrical storm in Brugada syndrome requires elimination of precipitating factors, isoproterenol, and oral quinidine, followed by ablation if initial measures fail.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: